NeOnc Technologies Holdings is trading 6.1% higher at $3.70 as broader market optimism and strong large-cap tech earnings fuel a risk-on rally across the biotechnology sector.
- The upward move appears driven by macro factors and sector-wide momentum rather than any fresh company-specific filings or news catalysts.
- Biotechnology stocks are seeing a broad bid this morning, benefiting from a shift in investor sentiment toward higher-growth assets following positive earnings from large-cap technology peers.